Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72808 record(s)

Req # A-2021-001496

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_04403239, E2B_04478607, E2B_04410041, E2B_04374569, E2B_04396043, E2B_04392143, E2B_04370904, E2B_04371940, E2B_04411181, E2B_04411529, E2B_04411619, E2B_04475791,…

Organization: Health Canada

467 page(s)
April 2024

Req # A-2021-001595

Adverse Drug Reactions (ADRs). Report numbers: E2B_04517612, E2B_04533637, 000970662, E2B_04580127, 000962489, 000966607, 000969985, E2B_04607680, E2B_02153005, E2B_03530953, E2B_04582750, E2B_04502921, E2B_04528744, E2B_04513381, E2B_04512231,…

Organization: Health Canada

318 page(s)
April 2024

Req # A-2021-001982

Adverse Drug Reactions (ADRs). Report numbers: E2B_04809512, E2B_04814716, E2B_04788436, E2B_04816188, E2B_04797467, E2B_04778253, E2B_04821689, E2B_04821722, E2B_04782548, 000973761, E2B_04752615, E2B_04816220, 000970576, E2B_04247184, E2B_04797500…

Organization: Health Canada

294 page(s)
April 2024

Req # A-2021-002023

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-108457-361.

Organization: Health Canada

33 page(s)
April 2024

Req # A-2022-000778

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108685-224.

Organization: Health Canada

21 page(s)
April 2024

Req # A-2022-001613

Adverse Drug Reactions (ADRs). Report numbers: E2B_02421473, E2B_02432885, 000972235, E2B_04582728, E2B_02476812, 000729247, E2B_02540141, 000729578, E2B_02568224, E2B_02640414.

Organization: Health Canada

162 page(s)
April 2024

Req # A-2023-000106

Adverse Drug Reactions (ADRs). Report numbers: E2B_05651003, E2B_03722288, E2B_03692076, E2B_05075695, E2B_05638768, E2B_05957614, E2B_04794794, E2B_01281932, E2B_04813234, E2B_04528744.

Organization: Health Canada

1814 page(s)
April 2024

Req # A-2023-000215

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101449-414, Review of the Fraud Risk Assessment Process at Health Canada.

Organization: Health Canada

13 page(s)
April 2024

Req # A-2023-000782

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-075176-860.

Organization: Health Canada

7 page(s)
April 2024

Req # A-2023-000785

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-106521-709, Launch of the Science Competency Development Roadmap.

Organization: Health Canada

12 page(s)
April 2024
Date modified: